In a recent episode of Science Vs — a podcast that’s kind of a “Mythbusters” for social media — the ...
If you’re at McKesson’s IdeaShare event in Denver this coming weekend (or even today), check out APC...
CBS News published an investigation this week into the booming gray market for retatrutide — an expe...
The Texas Board of Pharmacy on Wednesday finally passed its updated rules for compounding. If you li...
Even pharmacists can lose an initialism or acronym or two in a metaphorical bowl of alphabet soup. T...
Sara Talpos’s article about peptides in Undark (and also published in Stat News) might be the most t...
There’s good news on the drug-shortages front, according to the latest report from the American Soci...
HHS’s Office of the Inspector General has issued a new advisory bulletin about pharma manufacturers ...
With patents for semaglutide expiring in the not-too-distant future, Novo Nordisk is pulling out all...
According to a ProPublica analysis, “the FDA has lost more than 400 workers who support inspections ...